| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |